BioPharma-Reporter » Biosimilars
174 FOLLOWERS
Take a peek into the news on the biopharmaceutical manufacturing industry, focusing on biologics, biosimilars, technology, upstream/downstream processing, cell culture, and regulations. William Reed's BioPharma-Reporter has been the leading online news source for the biopharma industry for more than 8 years, leveraging our digital-first position to bring powerful insights and robust..
BioPharma-Reporter » Biosimilars
22h ago
AbbVie is acquiring rival biotech firm ImmunoGen for $10.1 billion, giving it access to ImmunoGen's flagship ovarian cancer treatment Elahere, which was granted accelerated approval from the FDA last year ..read more
BioPharma-Reporter » Biosimilars
2d ago
A Life Sciences Advisory Board has been launched by Atropos Health, a company that translates data into personalized real-world insights across healthcare ..read more
BioPharma-Reporter » Biosimilars
2d ago
Lumen Bioscience, a clinical-stage biopharma company developing biologic drugs for highly prevalent disease, has received $5.5 million in new funding from the U.S. Department of Defense, to develop technologies for needle-free vaccines ..read more
BioPharma-Reporter » Biosimilars
2d ago
PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), has received approval to continue its BIOPATTERN trial following recruitment of the first ten patients with CAD ..read more
BioPharma-Reporter » Biosimilars
4d ago
Outsourcing Pharma is delighted to invite you to join our not-to-be-missed webinar on one of the most important areas of the industry â patient centricity â and its solutions ..read more
BioPharma-Reporter » Biosimilars
4d ago
Hilleman Laboratories has opened a new 30,000 sq ft manufacturing facility in Singapore ..read more
BioPharma-Reporter » Biosimilars
4d ago
Cradle, the biotech startup using generative AI to help scientists design and engineer proteins, has raised $24 million in Series A funding ..read more
BioPharma-Reporter » Biosimilars
4d ago
While the biotech industry has faced funding difficulties after peaking during the Covid-19 years, CDMO CordenPharma is managing to weather the storm ..read more
BioPharma-Reporter » Biosimilars
5d ago
While the biotech industry has faced funding difficulties after peaking during the Covid-19 years, CDMO Corden Pharma is managing to weather the storm ..read more
BioPharma-Reporter » Biosimilars
5d ago
Sanofi is planning to expand the market for its best-selling anti-inflammatory drug Dupixent, used to treat COPD, also known as âsmokers lungâ, after a successful second phase 3 trial ..read more